Alzheimer Disease

Showing NaN - NaN of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy, Alzheimer Trial in Australia, United Kingdom, United States (AL002, Saline Solution)

Completed
  • Healthy
  • Alzheimer Disease
  • AL002
  • Saline Solution
  • Delray Beach, Florida
  • +5 more
Dec 7, 2020

Alzheimer Trial in United States (Bryostatin, Placebo)

Completed
  • Alzheimer Disease
  • Fresno, California
  • +27 more
Sep 8, 2020

Alzheimer Trial in Canada, United States (Flortaucipir F18, Brain PET Scan)

Completed
  • Alzheimer Disease
  • Flortaucipir F18
  • Brain PET Scan
  • San Diego, California
  • +9 more
Aug 7, 2020

Alzheimer Trial in United States (Flortaucipir F18, Brain PET Scan)

Completed
  • Alzheimer Disease
  • Flortaucipir F18
  • Brain PET Scan
  • Irvine, California
  • +8 more
Aug 7, 2020

Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))

Completed
  • Alzheimer Disease
  • lecozotan SR (SRA-333)
  • Phoenix, Arizona
  • +82 more
Jul 1, 2020

Alzheimer Trial in Japan, United States (LY3002813, Placebo)

Completed
  • Alzheimer Disease
  • LY3002813
  • Placebo
  • Delray Beach, Florida
  • +8 more
Jun 10, 2020

Alzheimer Trial in Netherlands, United States (DNL747, Placebo)

Completed
  • Alzheimer Disease
  • Miami, Florida
  • +4 more
Feb 25, 2020

Alzheimer, Dementia Trial in Orlando (Performing Arts Instruction)

Completed
  • Alzheimer Disease
  • Dementia
  • Performing Arts Instruction
  • Orlando, Florida
    Dr. Phillips Center for the Performing Arts
Feb 18, 2020

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer Trial in United States (NPT088, Placebo)

Completed
  • Alzheimer Disease
  • Costa Mesa, California
  • +22 more
Aug 14, 2019

Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)

Completed
  • Alzheimer Disease
  • Crenezumab dose level 1
  • +3 more
  • Phoenix, Arizona
  • +12 more
Jul 23, 2019

Alzheimer Trial in Japan, United Kingdom, United States (LY3303560 - IV, Placebo - IV, Florbetapir F 18)

Completed
  • Alzheimer Disease
  • LY3303560 - IV
  • +3 more
  • Melbourne, Florida
  • +10 more
Jul 2, 2019

Alzheimer Trial in United States (LY3372993, Placebo)

Completed
  • Alzheimer Disease
  • Long Beach, California
  • +10 more
Jun 4, 2019

Alzheimer Trial in Worldwide (Placebo, BI 409306, Donepezil)

Completed
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Sherman Oaks, California
  • +59 more
Oct 18, 2018

Alzheimer Trial in San Diego, Orlando, Cincinnati (COR388, Placebo)

Completed
  • Alzheimer Disease
  • San Diego, California
  • +2 more
Nov 5, 2018

Alzheimer Trial in Japan, United States (LY3002813-IV, LY3002183-SC, Placebo-IV)

Completed
  • Alzheimer Disease
  • LY3002813-IV
  • +2 more
  • Long Beach, California
  • +5 more
Dec 21, 2017

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
  • Alzheimer Disease
  • Birmingham, Alabama
  • +286 more
May 3, 2016

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
  • Alzheimer Disease
  • Birmingham, Alabama
  • +347 more
Dec 4, 2015

Alzheimer Trial in Worldwide (Bapineuzumab 0.5 mg/kg)

Terminated
  • Alzheimer Disease
  • Bapineuzumab 0.5 mg/kg
  • Birmingham, Alabama
  • +182 more
Nov 30, 2015

Alzheimer Trial in United States (PF-04494700 - Low Dose Arm, PF-04494700 - High Dose Arm, Placebo Comparator)

Completed
  • Alzheimer Disease
  • PF-04494700 - Low Dose Arm
  • +2 more
  • Sun City, Arizona
  • +11 more
Aug 19, 2009

Alzheimer, Dementia Trial in United States (MPC-7869)

Completed
  • Alzheimer Disease
  • Dementia
  • Alabaster, Alabama
  • +132 more
May 3, 2009

Alzheimer Trial in Canada, United States (xaliproden (SR57746A))

Completed
  • Alzheimer Disease
  • xaliproden (SR57746A)
  • Birmingham, Alabama
  • +120 more
Aug 20, 2008

Alzheimer Trial in United States (Galantamine)

Completed
  • Alzheimer Disease
  • Birmingham, Alabama
  • +54 more
Jun 23, 2005